Maximising the highs and minimising the lows: Harm reduction guidance within ecstasy distribution networks

International Journal of Drug Policy

Volumn 19, Issue 5, 2008, Pages 393-400

  Jacinto, Camille ^a   Duterte, Micheline ^a   Sales, Paloma ^a   Murphy, Sheigla ^a  

^a Scientific Analysis Corporation   (United States)

Author keywords

Ecstasy; Ecstasy sellers; Harm reduction; Pleasure

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ARTICLE; DRUG MARKETING; DRUG TRAFFIC; EXPERIENCE; FEMALE; HARM REDUCTION; HUMAN; HUMAN RELATION; INFORMATION DISSEMINATION; INFORMATION SERVICE; INTERVIEW; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SAFETY; UNITED STATES;

ADULT; AMPHETAMINE-RELATED DISORDERS; ATTITUDE TO HEALTH; CODEPENDENCY (PSYCHOLOGY); FEMALE; HARM REDUCTION; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PERCEPTION; QUALITATIVE RESEARCH; RISK REDUCTION BEHAVIOR; RISK-TAKING; SAN FRANCISCO;

EID: 51649104048     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.09.003     Document Type: Article

References (40)

1. Allott K., and Redman J. Patterns of use and harm reduction practices of ecstasy users in Australia. Drug and Alcohol Dependence 82 (2006) 168-176
2. Baggot M. Preventing problems in ecstasy users: Reduce use to reduce harm. Journal of Psychoactive Drugs 34 (2002) 145-162
3. Beck J., and Rosenbaum M. Pursuit of ecstasy: The MDMA experience (1994), State University of New York Press, Albany
4. Becker H. Outsiders: Studies in the sociology of deviance (1963), Free Press, New York
5. Biernacki P., and Waldorf D. Snowball sampling: Problems, techniques and chain-referral sampling. Sociological Methods and Research 10 2 (1981) 141-163
6. Birdsall T. 5-Hydrotryptophan: A clinically-effective serotonin precursor. Alternative Medicine Review 3 4 (1998) 271-280
7. Buroway M., Burton A., Ferguson A., Fox K., Gamson J., Gartrell N., Hurst L., Kurzman C., Salziner L., Schiffman J., and Ui S. Ethnography unbound: Power and resistance in the modern metropolis (1991), University of California Press, Berkeley and Los Angeles, CA
8. Carlson R.G., Falck R.A., McCaughan J.A., and Siegal H.A. MDMA/Ecstasy use among young people in Ohio: Perceived risk and barriers to intervention. Journal of Psychoactive Drugs 36 2 (2004) 181-189
9. Charmaz K. Contemporary field research. In: Emerson R. (Ed). Contemporary field research (1983), Little-Brown, Boston 109-126
10. Copeland J., Dillon P., and Gascoigne M. Ecstasy and the concomitant use of pharmaceuticals. Addictive Behaviors 31 (2006) 367-370
11. Cottler L.B., Womack S.B., and Compton W.M. Ecstasy abuse and dependence: Applicability and reliability of DSM-IV criteria among adolescents and young adults. Human Psychopharmacology 16 (2001) 599-606
12. Curran H.V., and Travill R.A. Mood and cognitive effects of ±3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): Week-end 'high' followed by mid-week low. Addiction 92 7 (1997) 821-831
13. Erowid (2001, December). Do antioxidants protect against MDMA hangover, tolerance and neurotoxicity? Erowid Extracts, 2: 6-11. Retrieved from http://www.erowid.org/chemicals/mdma/mdma_article3.shtml.
14. Falck R.S., Carlson R.G., Wang J., and Siegal H.A. Sources of information about MDMA (3,4-methylenedioxymethamphetamine): Perceived accuracy, importance, and implications for prevention among young adult users. Drug and Alcohol Dependence 74 1 (2004) 45-54
15. Gamma A., Jerome L., Liechti M.E., and Lumnall H.R. Is ecstasy perceived to be safe? A critical survey. Drug and Alcohol Dependence 77 2 (2005) 185-193
16. Glaser B., and Strauss A. The discovery of grounded theory (1967), Aldine, Chicago
17. Gourley M. A subcultural study of recreational ecstasy use. Journal of Sociology 40 1 (2004) 59-73
18. Hansen D., Maycock B., and Lower T. 'Weddings, parties, anything...', A qualitative analysis of ecstasy use in Perth, Western Australia. International Journal of Drug Policy 12 (2001) 181-199
19. Hinchcliff S. The meaning of ecstasy use and clubbing to women in the late 1990s. International Journal of Drug Policy 12 (2001) 455-468
20. Hunt G.P., Evans K., and Kares F. Drug use and meanings of risk and pleasure. Journal of Youth Studies 10 1 (2007) 73-96
21. Jacinto, C., Duterte, M., Sales, P., & Murphy, S. (2008). 'I'm not a real dealer': The identity process of Ecstasy sellers. Journal of Drug Issues, in press.
22. Kuzel A. Sampling in qualitative inquiry. In: Crabtree B.F., and Miller W.L. (Eds). Doing qualitative research (1992), Sage, Newbury Park, CA 31-45
23. Lieb R., Schuetz C.G., Pfister H., von Sydow K., and Wittchen H. Mental disorders in ecstasy users: A prospective longitudinal investigation. Drug and Alcohol Dependence 68 (2002) 195-207
24. MacInnes N., Handley S.L., and Harding G.F.A. Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms. Journal of Psychopharmacology 15 3 (2001) 181-186
25. Measham F., Aldridge J., and Parker H. Dancing on drugs: Risks, health and hedonism in the British Club Scene (2001), Free Association Books, London
26. Murphy P.N., Wareing M., and Fisk J.E. Users' perceptions of the risks and effects of taking ecstasy (MDMA): A questionnaire study. Journal of Psychopharmacology 20 3 (2006) 447-455
27. Parrott A.C. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine). Journal of Psychopharmacology 19 1 (2005) 75-87
28. Parrott A.C., and Lasky J. Ecstasy (MDMA) effects upon mood and cognition: Before, during and after a Saturday night dance. Psychopharmacology 139 (1998) 261-269
29. Rodgers J., Buchanan T., Pearson C., Parrott A.C., Ling J., Heffernan T., and Scholey A.B. Differential experiences of the psychobiological sequelae of ecstasy use: Quantitative and qualitative data from an internet study. Journal of Psychopharmacology 20 3 (2006) 437-446
30. Schensul J.J., Diamond S., Disch W., Bermudez R., and Eiserman J. The diffusion of ecstasy through urban youth networks. Journal of Ethnicity in Substance Abuse 4 2 (2005) 39-71
31. Shewan D., Dalgarno P., and Reith G. Perceived risk and risk reduction among ecstasy users: The role of drug, set and setting. International Journal of Drug Policy 10 (2000) 431-453
32. Soar K., Turner J.J.D., and Parrott A.C. Problematic versus non-problematic ecstasy/MDMA use: The influence of drug usage patterns and pre-existing psychiatric factors. Journal of Psychopharmacology 20 3 (2006) 417-424
33. Southgate E., and Hopwood M. The role of folk pharmacology and lay experts in harm reduction: Sydney gay drug using networks. International Journal of Drug Policy 12 (2001) 321-335
34. Sprague J.E., Huang X., Kanthasamy A., and Nichols D.E. Attenuation of 3,4 methylenedioxymethamphetamine (MDMA) induced neurotoxicity with the serotonin precursors tryptophan and 5-hydroxytryptophan. Life Science 55 15 (1994) 1193-1198
35. Strauss A., and Corbin J. Basics of qualitative research (1990), Sage Publications, Newbury Park, CA
36. Verheyden S.L., Maidment R., and Curran H.V. Quitting ecstasy: An investigation of why people stop taking the drug and their subsequent mental health. Journal of Psychopharmacology 17 4 (2003) 371-378
37. Watters J., and Biernacki P. Targeted sampling: Options for the study of hidden populations. Social Problems 36 4 (1989) 416-430
38. Weir E. Raves: A review of the culture, the drugs and the prevention of harm. Canadian Medical Association Journal 162 13 (2000) 1843-1848
39. White B., Degenhardt L., Breen C., Bruno R., Newman J., and Proudfoot P. Risk and benefit perception of party drug use. Addictive Behaviors 31 (2006) 137-142
40. Zinberg N.E. Drug, set and setting: The basis for controlled intoxicant use (1984), Yale University Press, New Haven, CT